Effect of Nutrient Delivery Pattern on Biological Rhythms in Human Skeletal Muscle
1 other identifier
interventional
18
1 country
1
Brief Summary
Recent work has established biological rhythms in human skeletal muscle. It remains unknown how the timing and pattern of meals influences these rhythms. Therefore, this study sets out to establish how frequent (CONSTANT) vs infrequent (BOLUS) feeding patterns influence established biological rhythms in skeletal muscle.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Feb 2019
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 28, 2019
CompletedFirst Submitted
Initial submission to the registry
April 4, 2019
CompletedFirst Posted
Study publicly available on registry
April 8, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 28, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
February 28, 2022
CompletedApril 14, 2023
April 1, 2023
3 years
April 4, 2019
April 13, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Autophagy
Rhythms in autophagy with different feeding patterns
4 hours
Transcriptomic, rhythms in human skeletal muscle
Assessing rhythms in core-clock genes within the muscle samples
Over a 24-hour period at a 4 hour resolution
Secondary Outcomes (2)
Endocrine responses of systemic blood plasma over 24-hours
24-hours
Continuously monitored subcutaneous interstitial glucose concentrations
48-hours
Study Arms (2)
Constant
ACTIVE COMPARATORParticipants will be provided with their daily energy requirements in a continuous drip across the day (1 ml/minute).
Bolus
EXPERIMENTALParticipants will be provided with their daily energy requirements in two bolus feeds. One at 08:00-08:15 and one at 20:00-20:15
Interventions
Eligibility Criteria
You may qualify if:
- Body mass index \>19 but \<30 kg/m2
- Be able and willing to give informed oral and written consent, complete and meet the defined criteria of pre-study questionnaires and screens,
- Have a regular sleep cycle with a sleep duration between 6 and 8 hours, do not exhibit extreme morning or evening preference (Horne and Ostberg, 1976)
- Agree to keep a constant sleep/wake cycle with a self-selected 8 hour sleep duration (from which it cannot be deviated by more than 30 minutes) for one week prior to the lab study,
- Obtain 15 minutes of sunlight within 1.5 hours of waking up and agree to nap only within a 4 h designated nap window for one week prior to the lab study,
- Allow confirmation of compliance to these instructions by wearing ActiHeart monitors continuously and complete daily sleep and event diaries for one week before the study session,
- Agree to refrain from alcohol, caffeine, heavy exercise and certain food components TWO days before the study session,
- Agree to weigh and record daily meals (based on individual energy requirements) for TWO days prior to the study,
- Agree to refrain from prescribed and 'over the counter' medication and food/vitamin supplements for a wash-out period three weeks before and during the study.
You may not qualify if:
- Are taking regular medication (also non-prescribed) or food supplements (e.g vitamins, minerals, fish oil, antioxidant tablets) from which it is not possible to refrain, known to influence: Sleep/alertness/the circadian timing system (e.g beta-blockers, barbituates, antidepressants, benzodiazepines, melatonin, ritalin, modafinil, soporifics, St John's Wort), any of the metabolic functions (e.g. affecting thyroid, kidney, liver or gastrointestinal function)
- Any of the inflammatory markers (e.g. aspirin, ibuprofen, antiobiotics, hay fever medication, medication for sore throats and colds)
- And/or any of the endothelial markers (e.g. ACE inhibitors and angiotensin (receptor) blockers, diuretics, Beta-blockers, anti-thrombosis medication),
- Have a history of psychiatric or neurological disease or drug and alcohol abuse,
- Have donated over 400 ml of blood in the three months preceding the study,
- Have participated in shift work or have travelled across more than two time zones within three weeks of the study,
- Do not keep a regular sleep-wake cycle,
- Do not refrain from alcohol, caffeine containing drinks (e.g. coffee, coke, tea, redbull), heavy exercise and certain foods (e.g. those high in fat and green vegetables) TWO days before and during the laboratory session,
- Normally consume more than 4 cups of caffeinated beverages (e.g. tea, coffee, cola) daily
- Smokers
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Bathlead
- Société des Produits Nestlé (SPN)collaborator
Study Sites (1)
University of Bath
Bath, Somerset, BA2 7AY, United Kingdom
Related Publications (2)
Christou S, Wehrens SMT, Isherwood C, Moller-Levet CS, Wu H, Revell VL, Bucca G, Skene DJ, Laing EE, Archer SN, Johnston JD. Circadian regulation in human white adipose tissue revealed by transcriptome and metabolic network analysis. Sci Rep. 2019 Feb 25;9(1):2641. doi: 10.1038/s41598-019-39668-3.
PMID: 30804433BACKGROUNDPerrin L, Loizides-Mangold U, Chanon S, Gobet C, Hulo N, Isenegger L, Weger BD, Migliavacca E, Charpagne A, Betts JA, Walhin JP, Templeman I, Stokes K, Thompson D, Tsintzas K, Robert M, Howald C, Riezman H, Feige JN, Karagounis LG, Johnston JD, Dermitzakis ET, Gachon F, Lefai E, Dibner C. Transcriptomic analyses reveal rhythmic and CLOCK-driven pathways in human skeletal muscle. Elife. 2018 Apr 16;7:e34114. doi: 10.7554/eLife.34114.
PMID: 29658882BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Harry A Smith, MSci
University of Bath
- PRINCIPAL INVESTIGATOR
James A Betts, PhD
University of Bath
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor James Betts
Study Record Dates
First Submitted
April 4, 2019
First Posted
April 8, 2019
Study Start
February 28, 2019
Primary Completion
February 28, 2022
Study Completion
February 28, 2022
Last Updated
April 14, 2023
Record last verified: 2023-04